Balance Sheet Incyte Corporation

Equities

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 12/05/2026 am IST			5-day change	1st Jan Change
100.32 ^USD	+1.79%		+3.52%	+1.57%

07/05	Incyte Announces 24-Week Data For Opzelura Cream In Adults With Moderate Atopic Dermatitis	CI
02/05	Incyte Announces Fda Approval of Jakafi Xr Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease	CI

c9d38.5NXS7TvwzaoaTQPzOCYS5_RxjdAmuoTQsaM-64K0WKE.nOHlvlDGqcJ7PlafbE9To74C6pVS3La7xMEI3M7FDO6ttP-kbbqF0nkeWg

Published financial data: INCYTE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	298.63Cr	339.46Cr	369.56Cr	424.12Cr	514.12Cr
Other Revenues, Total	-	-	-	-	-
Total Revenues	298.63Cr	339.46Cr	369.56Cr	424.12Cr	514.12Cr
Cost of Goods Sold, Total	164.62Cr	180.09Cr	188.46Cr	290.66Cr	242.23Cr
Gross Profit	134.01Cr	159.37Cr	181.1Cr	133.46Cr	271.9Cr
Selling General & Admin Expenses, Total	74Cr	100Cr	115.87Cr	121.87Cr	137.25Cr
Other Operating Expenses, Total	74Cr	100Cr	115.87Cr	121.87Cr	137.25Cr
Operating Income	60Cr	59Cr	65Cr	12Cr	134.65Cr
Interest Expense, Total	-19.08L	-26.66L	-25.51L	-22.8L	-24.28L
Interest And Investment Income	-	-	17Cr	13Cr	11Cr
Net Interest Expenses	-19.08L	-26.66L	17Cr	13Cr	10Cr
Other Non Operating Income (Expenses)	1.2Cr	3.71Cr	-	95.29L	2.14Cr
EBT, Excl. Unusual Items	61Cr	63Cr	82Cr	25Cr	147.1Cr
Merger & Related Restructuring Charges	-	-	-	-3.15Cr	-
Gain (Loss) On Sale Of Investments	-2.41Cr	-8.76Cr	4.39Cr	12Cr	2.13Cr
Asset Writedown	-	-	-	-	-7.63Cr
Legal Settlements	-	-	-	-	24Cr
Other Unusual Items	-1.47Cr	-1.21Cr	-2.92Cr	-1.98Cr	61.29L
EBT, Incl. Unusual Items	57Cr	53Cr	83Cr	32Cr	166.45Cr
Income Tax Expense	-38Cr	19Cr	24Cr	28Cr	38Cr
Earnings From Continuing Operations	95Cr	34Cr	60Cr	3.26Cr	128.66Cr
Net Income to Company	95Cr	34Cr	60Cr	3.26Cr	128.66Cr
Net Income - (IS)	95Cr	34Cr	60Cr	3.26Cr	128.66Cr
Net Income to Common Incl Extra Items	95Cr	34Cr	60Cr	3.26Cr	128.66Cr
Net Income to Common Excl. Extra Items	95Cr	34Cr	60Cr	3.26Cr	128.66Cr
Per Share Items
Net EPS - Basic	4.3	1.53	2.67	0.16	6.59
Basic EPS - Continuing Operations	4.3	1.53	2.67	0.16	6.59
Basic Weighted Average Shares Outstanding	22Cr	22Cr	22Cr	21Cr	20Cr
Net EPS - Diluted	4.27	1.52	2.65	0.15	6.41
Diluted EPS - Continuing Operations	4.27	1.52	2.65	0.15	6.41
Diluted Weighted Average Shares Outstanding	22Cr	22Cr	23Cr	21Cr	20Cr
Normalized Basic EPS	1.73	1.77	2.29	0.76	4.71
Normalized Diluted EPS	1.71	1.75	2.27	0.75	4.58
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	66Cr	67Cr	74Cr	21Cr	143.98Cr
EBITA	62Cr	62Cr	67Cr	14Cr	137.32Cr
EBIT	60Cr	59Cr	65Cr	12Cr	134.65Cr
EBITDAR	67Cr	68Cr	75Cr	22Cr	144.75Cr
Total Revenues (As Reported)	298.63Cr	339.46Cr	369.56Cr	424.12Cr	514.12Cr
Effective Tax Rate - (Ratio)	-66.29	35.62	28.36	89.7	22.7
Current Domestic Taxes	8.31Cr	13Cr	39Cr	37Cr	12Cr
Current Foreign Taxes	43.97L	31.41L	30.01L	29.31L	66.1L
Total Current Taxes	8.75Cr	13Cr	40Cr	37Cr	13Cr
Deferred Domestic Taxes	-41Cr	5.84Cr	-16Cr	-8.47Cr	25Cr
Deferred Foreign Taxes	-75T	-13.07L	2L	-8L	3L
Total Deferred Taxes	-41Cr	5.71Cr	-16Cr	-8.56Cr	25Cr
Normalized Net Income	38Cr	39Cr	51Cr	16Cr	92Cr
Interest on Long-Term Debt	13L	14L	13L	13L	13L
Non-Cash Pension Expense	14.03L	-28.04L	-26.37L	-32.8L	-37.3L
Supplemental Operating Expense Items
Advertising Expense	6.6Cr	20Cr	22Cr	20Cr	16Cr
Selling and Marketing Expenses	6.6Cr	20Cr	22Cr	20Cr	16Cr
Research And Development Expense From Footnotes	148.78Cr	163.81Cr	167.67Cr	263.67Cr	206.62Cr
Net Rental Expense, Total	1.5Cr	1.17Cr	98L	81L	77L
Imputed Operating Lease Interest Expense	37.49L	43.03L	36.99L	26.17L	25.95L
Imputed Operating Lease Depreciation	1.13Cr	73.97L	61.01L	54.83L	51.05L
Stock-Based Comp., COGS (Total)	12Cr	12Cr	13Cr	16Cr	15Cr
Stock-Based Comp., SG&A Exp. (Total)	6.7Cr	7.32Cr	8.61Cr	10Cr	9.56Cr
Stock-Based Comp., Other (Total)	-	-	-	-	46T
Total Stock-Based Compensation	18Cr	19Cr	22Cr	27Cr	25Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	205.74Cr	295.14Cr	321.34Cr	168.78Cr	309.78Cr
Short Term Investments	29Cr	29Cr	44Cr	47Cr	48Cr
Total Cash And Short Term Investments	234.82Cr	323.9Cr	365.6Cr	215.81Cr	358.06Cr
Accounts Receivable, Total	62Cr	64Cr	74Cr	85Cr	102.44Cr
Other Receivables	-	-	-	-	-
Total Receivables	62Cr	64Cr	74Cr	85Cr	102.44Cr
Inventory	2.79Cr	4.2Cr	6.3Cr	5.89Cr	10Cr
Prepaid Expenses	13Cr	17Cr	18Cr	17Cr	32Cr
Restricted Cash	-	-	-	-	-
Total Current Assets	311.87Cr	409.28Cr	464.54Cr	323.9Cr	502.39Cr
Gross Property Plant And Equipment	93Cr	98Cr	104.7Cr	112.22Cr	113.35Cr
Accumulated Depreciation	-18Cr	-21Cr	-27Cr	-33Cr	-38Cr
Net Property Plant And Equipment	75Cr	77Cr	78Cr	79Cr	76Cr
Long-term Investments	22Cr	13Cr	19Cr	1.88Cr	4.8Cr
Goodwill	16Cr	16Cr	16Cr	16Cr	13Cr
Other Intangibles, Total	15Cr	13Cr	12Cr	11Cr	12Cr
Deferred Tax Assets Long-Term	47Cr	46Cr	63Cr	76Cr	52Cr
Other Long-Term Assets, Total	6.81Cr	11Cr	26Cr	36Cr	36Cr
Total Assets	493.34Cr	584.1Cr	678.21Cr	544.43Cr	695.8Cr
Liabilities
Accounts Payable, Total	17Cr	28Cr	11Cr	20Cr	21Cr
Accrued Expenses, Total	56Cr	76Cr	97Cr	131.25Cr	115.84Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	1.32Cr	1.14Cr	91.25L	1Cr	1.02Cr
Current Income Taxes Payable	-	-	4.23Cr	2.38Cr	47.55L
Other Current Liabilities	11Cr	11Cr	11Cr	9.81Cr	13Cr
Total Current Liabilities	85Cr	115.71Cr	124.04Cr	164.18Cr	151.52Cr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	4.72Cr	4.42Cr	4.34Cr	5.03Cr	4.47Cr
Pension & Other Post Retirement Benefits	3.8Cr	1.17Cr	4.12Cr	4.59Cr	4.12Cr
Other Non Current Liabilities	22Cr	26Cr	27Cr	26Cr	19Cr
Total Liabilities	116.33Cr	147.09Cr	159.23Cr	199.67Cr	179.05Cr
Common Stock, Total	2L	2L	2L	2L	2L
Additional Paid In Capital	456.71Cr	479.2Cr	501.61Cr	453.34Cr	492.8Cr
Retained Earnings	-78Cr	-44Cr	16Cr	-107.29Cr	21Cr
Comprehensive Income and Other	-1.95Cr	1.51Cr	1.31Cr	-1.31Cr	2.55Cr
Total Common Equity	377Cr	437.01Cr	518.98Cr	344.76Cr	516.75Cr
Total Equity	377Cr	437.01Cr	518.98Cr	344.76Cr	516.75Cr
Total Liabilities And Equity	493.34Cr	584.1Cr	678.21Cr	544.43Cr	695.8Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	22Cr	22Cr	22Cr	19Cr	20Cr
ECS Total Common Shares Outstanding	22Cr	22Cr	22Cr	19Cr	20Cr
Book Value / Share	17.05	19.62	23.14	17.82	26.04
Tangible Book Value	346.37Cr	408.53Cr	491.07Cr	317.82Cr	491.73Cr
Tangible Book Value Per Share	15.67	18.34	21.89	16.43	24.78
Total Debt	6.04Cr	5.56Cr	5.26Cr	6.03Cr	5.49Cr
Net Debt	-228.78Cr	-318.34Cr	-360.35Cr	-209.78Cr	-352.57Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.8Cr	1.17Cr	4.12Cr	4.59Cr	4.12Cr
Debt Equivalent Oper. Leases	12Cr	9.36Cr	7.84Cr	6.48Cr	6.16Cr
Account Code - Inventory Valuation	8	8	8	8	8
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	1.05Cr	1.04Cr	1.09Cr	1.54Cr	1.13Cr
Buildings, Total	43Cr	56Cr	58Cr	60Cr	61Cr
Machinery, Total	21Cr	31Cr	39Cr	41Cr	43Cr
Full Time Employees	2.09T	2.32T	2.52T	2.62T	2.84T

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	95Cr	34Cr	60Cr	3.26Cr	128.66Cr
Depreciation & Amortization - CF	3.9Cr	4.95Cr	6.37Cr	6.95Cr	6.66Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.15Cr	2.15Cr	2.25Cr	2.36Cr	2.67Cr
Depreciation & Amortization, Total	6.05Cr	7.1Cr	8.62Cr	9.31Cr	9.33Cr
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	2.41Cr	8.76Cr	-4.39Cr	-12Cr	-2.13Cr
Asset Writedown & Restructuring Costs	-	-	-	-	7.63Cr
Stock-Based Compensation (CF)	18Cr	19Cr	22Cr	27Cr	25Cr
Other Operating Activities, Total	-45Cr	8.35Cr	-11Cr	-7.87Cr	26Cr
Change In Accounts Receivable	-13Cr	-2.86Cr	-9.87Cr	-11Cr	-17Cr
Change In Inventories	-2.1Cr	-6.75Cr	-17Cr	-13Cr	-5.85Cr
Change In Accounts Payable	7.33Cr	11Cr	-17Cr	8.82Cr	65.62L
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	6.74Cr	19Cr	19Cr	29Cr	-30Cr
Cash from Operations	75Cr	97Cr	50Cr	34Cr	141.35Cr
Capital Expenditure	-18Cr	-7.78Cr	-3.25Cr	-8.63Cr	-5.89Cr
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-1.5Cr	-1.39Cr	-2.5Cr
Investment in Marketable and Equity Securities, Total	-2.67Cr	-7L	-16Cr	26Cr	-1.87Cr
Cash from Investing	-21Cr	-7.85Cr	-21Cr	16Cr	-10Cr
Long-Term Debt Repaid, Total	-24.17L	-28.62L	-33.6L	-37.98L	-45.44L
Total Debt Repaid	-24.17L	-28.62L	-33.6L	-37.98L	-45.44L
Issuance of Common Stock	5.86Cr	6.11Cr	3.58Cr	4.93Cr	22Cr
Repurchase of Common Stock	-2.99Cr	-2.63Cr	-2.86Cr	-204.51Cr	-9.59Cr
Other Financing Activities, Total	-2.01Cr	-3.27Cr	-2.4Cr	-2.2Cr	-2.03Cr
Cash from Financing	61.76L	-8L	-2Cr	-202.15Cr	10Cr
Foreign Exchange Rate Adjustments	-35.7L	33.55L	-66.76L	29.23L	-17.09L
Net Change in Cash	54Cr	89Cr	26Cr	-152.58Cr	141.02Cr
Supplemental Items
Cash Interest Paid	4L	-	-	-	-
Cash Income Tax Paid (Refund)	6.77Cr	14Cr	38Cr	37Cr	21Cr
Levered Free Cash Flow	45Cr	77Cr	61Cr	64Cr	61Cr
Unlevered Free Cash Flow	45Cr	77Cr	61Cr	64Cr	61Cr
Change In Net Working Capital	-1.29Cr	-22Cr	4.99Cr	-31Cr	49Cr
Net Debt Issued / Repaid	-24.17L	-28.62L	-33.6L	-37.98L	-45.44L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.82	6.9	6.46	1.19	13.57
Return on Total Capital	11.52	9	8.43	1.66	19.28
Return On Equity %	29.73	8.37	12.5	0.76	29.87
Return on Common Equity	29.73	8.37	12.5	0.76	29.87
Margin Analysis
Gross Profit Margin %	44.87	46.95	49	31.47	52.89
SG&A Margin	24.81	29.44	31.35	28.73	26.7
EBITDA Margin %	22.09	19.6	19.98	4.93	28
EBITA Margin %	20.78	18.14	18.26	3.29	26.71
EBIT Margin %	20.06	17.51	17.65	2.73	26.19
Income From Continuing Operations Margin %	31.76	10.04	16.17	0.77	25.03
Net Income Margin %	31.76	10.04	16.17	0.77	25.03
Net Avail. For Common Margin %	31.76	10.04	16.17	0.77	25.03
Normalized Net Income Margin	12.75	11.58	13.86	3.71	17.88
Levered Free Cash Flow Margin	15.03	22.76	16.53	15.07	11.86
Unlevered Free Cash Flow Margin	15.07	22.81	16.57	15.1	11.89
Asset Turnover
Asset Turnover	0.7	0.63	0.59	0.69	0.83
Fixed Assets Turnover	4.46	4.48	4.79	5.4	6.62
Receivables Turnover (Average Receivables)	5.44	5.38	5.32	5.31	5.48
Inventory Turnover (Average Inventory)	74.27	51.53	35.91	47.71	30.29
Short Term Liquidity
Current Ratio	3.65	3.54	3.75	1.97	3.32
Quick Ratio	3.47	3.36	3.55	1.83	3.04
Operating Cash Flow to Current Liabilities	0.88	0.84	0.4	0.2	0.93
Days Sales Outstanding (Average Receivables)	67.12	67.8	68.56	68.89	66.65
Days Outstanding Inventory (Average Inventory)	4.91	7.08	10.16	7.67	12.05
Average Days Payable Outstanding	29.82	45.21	37.08	19.36	30.17
Cash Conversion Cycle (Average Days)	42.21	29.67	41.65	57.21	48.53
Long Term Solvency
Total Debt/Equity	1.6	1.27	1.01	1.75	1.06
Total Debt / Total Capital	1.58	1.26	1	1.72	1.05
LT Debt/Equity	1.25	1.01	0.84	1.46	0.87
Long-Term Debt / Total Capital	1.23	1	0.83	1.43	0.86
Total Liabilities / Total Assets	23.58	25.18	23.48	36.67	25.73
EBIT / Interest Expense	314	222.95	255.73	50.85	554.57
EBITDA / Interest Expense	353.59	253.96	293.35	95.26	596.16
(EBITDA - Capex) / Interest Expense	258.73	224.76	280.61	57.43	571.91
Total Debt / EBITDA	0.09	0.08	0.07	0.28	0.04
Net Debt / EBITDA	-3.39	-4.7	-4.82	-9.66	-2.44
Total Debt / (EBITDA - Capex)	0.12	0.09	0.07	0.46	0.04
Net Debt / (EBITDA - Capex)	-4.63	-5.31	-5.03	-16.02	-2.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.98	13.67	8.87	14.76	21.22
Gross Profit, 1 Yr. Growth %	384.43	18.93	13.63	-26.31	105.46
EBITDA, 1 Yr. Growth %	-451.75	0.86	11	-71.69	728.9
EBITA, 1 Yr. Growth %	-382.43	-0.76	9.57	-79.32	1.17T
EBIT, 1 Yr. Growth %	-348.35	-0.79	9.75	-82.23	1.49T
Earnings From Cont. Operations, 1 Yr. Growth %	-420.79	-64.09	75.42	-94.54	3.84T
Net Income, 1 Yr. Growth %	-420.79	-64.09	75.42	-94.54	3.84T
Normalized Net Income, 1 Yr. Growth %	-377.87	3.22	30.32	-69.26	567.41
Diluted EPS Before Extra, 1 Yr. Growth %	-413.97	-64.4	74.34	-94.34	4.17T
Accounts Receivable, 1 Yr. Growth %	27.86	4.64	15.3	14.74	20.07
Inventory, 1 Yr. Growth %	69.89	50.5	49.95	-6.51	71.66
Net Property, Plant and Equip., 1 Yr. Growth %	27.78	1.88	1.49	2.21	-4.51
Total Assets, 1 Yr. Growth %	38.54	18.4	16.11	-19.73	27.8
Tangible Book Value, 1 Yr. Growth %	51.69	17.95	20.2	-35.28	54.72
Common Equity, 1 Yr. Growth %	44.37	15.92	18.76	-33.57	49.88
Cash From Operations, 1 Yr. Growth %	-701.52	29.41	-48.81	-32.46	321.52
Capital Expenditures, 1 Yr. Growth %	-3.4	-57	-58.26	165.54	-31.76
Levered Free Cash Flow, 1 Yr. Growth %	-363.2	72.17	-20.94	4.64	-0.97
Unlevered Free Cash Flow, 1 Yr. Growth %	-364.92	72.08	-20.9	4.6	-0.96
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.61	12.83	11.25	11.78	17.95
Gross Profit, 2 Yr. CAGR %	22.68	140.03	16.25	-8.49	22.53
EBITDA, 2 Yr. CAGR %	17.76	88.71	5.81	-43.94	39.42
EBITA, 2 Yr. CAGR %	18.41	67.42	4.28	-52.4	42.05
EBIT, 2 Yr. CAGR %	19.28	56.97	4.35	-55.83	43.05
Earnings From Cont. Operations, 2 Yr. CAGR %	45.69	7.33	-20.63	-69.06	46.73
Net Income, 2 Yr. CAGR %	45.69	7.33	-20.63	-69.06	46.73
Normalized Net Income, 2 Yr. CAGR %	13.61	69.35	15.98	-36.71	33.52
Diluted EPS Before Extra, 2 Yr. CAGR %	44.32	5.72	-21.22	-68.59	55.53
Accounts Receivable, 2 Yr. CAGR %	42.17	15.67	9.84	15.02	17.38
Inventory, 2 Yr. CAGR %	56.45	59.9	50.22	18.4	26.68
Net Property, Plant and Equip., 2 Yr. CAGR %	35.94	14.1	1.69	1.85	-1.21
Total Assets, 2 Yr. CAGR %	19.99	28.07	17.25	-3.46	1.29
Tangible Book Value, 2 Yr. CAGR %	24.1	33.76	19.07	-11.8	0.07
Common Equity, 2 Yr. CAGR %	20.45	29.37	17.33	-11.18	-0.22
Cash From Operations, 2 Yr. CAGR %	2.7	179.01	-18.61	-41.2	68.73
Capital Expenditures, 2 Yr. CAGR %	52.27	-35.55	-57.64	5.28	34.61
Levered Free Cash Flow, 2 Yr. CAGR %	-6.53	112.87	16.67	-9.04	-0.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.51	113.95	16.67	-9.04	-0.11
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.64	16.29	11.49	12.41	14.84
Gross Profit, 3 Yr. CAGR %	31.46	21.42	87.07	-0.14	19.49
EBITDA, 3 Yr. CAGR %	46.49	11.84	58.11	-31.82	29.34
EBITA, 3 Yr. CAGR %	52.1	11.64	45.36	-39.19	30.64
EBIT, 3 Yr. CAGR %	56.98	12.17	39.32	-42.16	31.33
Earnings From Cont. Operations, 3 Yr. CAGR %	105.38	-8.65	26.43	-67.48	55.73
Net Income, 3 Yr. CAGR %	105.38	-8.65	26.43	-67.48	55.73
Normalized Net Income, 3 Yr. CAGR %	48.62	10.04	55.19	-25.5	32.75
Diluted EPS Before Extra, 3 Yr. CAGR %	103.06	-9.49	24.9	-67.25	61.56
Accounts Receivable, 3 Yr. CAGR %	26.16	28.36	15.55	11.45	16.68
Inventory, 3 Yr. CAGR %	58.81	54.44	56.51	28.26	34.01
Net Property, Plant and Equip., 3 Yr. CAGR %	32.95	23.48	9.73	1.86	-0.31
Total Assets, 3 Yr. CAGR %	23.08	19.45	23.96	3.34	6.01
Tangible Book Value, 3 Yr. CAGR %	30.6	22.01	29.08	-2.83	6.37
Common Equity, 3 Yr. CAGR %	25.09	18.92	25.73	-2.94	5.75
Cash From Operations, 3 Yr. CAGR %	30.63	10.92	58.54	-23.52	13.37
Capital Expenditures, 3 Yr. CAGR %	35.05	-0.1	-44.24	-21.89	-8.89
Levered Free Cash Flow, 3 Yr. CAGR %	28.99	14.58	53.01	12.52	-7.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	28.91	14.58	53.56	12.5	-7.58
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	21.98	17.18	14.45	14.46	14.03
Gross Profit, 5 Yr. CAGR %	23.54	62.05	25.15	8.43	57.94
EBITDA, 5 Yr. CAGR %	28.16	31.09	28.62	-15.16	50.44
EBITA, 5 Yr. CAGR %	28.58	24.91	30.79	-20.62	44.27
EBIT, 5 Yr. CAGR %	29.58	21.55	33.32	-22.74	41.04
Earnings From Cont. Operations, 5 Yr. CAGR %	55.53	1.7	40.41	-40.76	34.19
Net Income, 5 Yr. CAGR %	55.53	1.7	40.41	-40.76	34.19
Normalized Net Income, 5 Yr. CAGR %	36.23	24.12	34.58	-11.8	46.33
Diluted EPS Before Extra, 5 Yr. CAGR %	51.22	-0.14	39.04	-40.73	36.35
Accounts Receivable, 5 Yr. CAGR %	32.99	19.49	19.36	22.85	16.28
Inventory, 5 Yr. CAGR %	46.71	45.31	55.32	38.87	43.82
Net Property, Plant and Equip., 5 Yr. CAGR %	34.99	24.13	19.43	14.33	5.22
Total Assets, 5 Yr. CAGR %	24.66	20.46	20.72	9.7	14.34
Tangible Book Value, 5 Yr. CAGR %	250.34	26.97	25.86	7.16	16.58
Common Equity, 5 Yr. CAGR %	55.14	21.79	21.93	5.82	14.63
Cash From Operations, 5 Yr. CAGR %	19.72	59.83	8.11	-13.95	62.54
Capital Expenditures, 5 Yr. CAGR %	8.52	-6.86	-15.06	2.02	-20.67
Levered Free Cash Flow, 5 Yr. CAGR %	21.5	44.66	23.91	4.47	29.02
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.65	45.77	23.86	4.47	29.29